AKT1 and metastatic neoplasm: We recently reported that increased expression of phosphorylated Akt (Serine-473) in the primary tumor was correlated with the invasive and metastatic potential of RCC, as well as with a worse response of metastatic disease to vascular endothelial growth factor targeting therapy and an unfavorable prognosis [15, 16].